Free Tool

R&D Tax Credit Eligibility Checker

Under the UK merged R&D scheme (April 2024 onward), profitable companies recover approximately 15p per £1 of qualifying spend, and loss-making R&D-intensive SMEs (≥30% intensity) recover up to 27p per £1 under ERIS. This 2-minute check tells you whether your activities show eligibility signals, gives an indicative recovery range, and produces a summary report you can share with an accountant or our specialist network. It is not tax advice.

Quick answer: Uplift Tax's free eligibility checker gives an indicative recovery range under the UK's merged R&D scheme in two minutes. Profitable companies typically recover around 15p per £1 spent; loss-making, R&D-intensive SMEs (spending at least 30% on R&D) can recover up to around 27p per £1 under ERIS. This is an eligibility indicator, not tax advice.

2 minute check No login required PDF report included

This tool indicates eligibility signals, not legal or tax advice

Uplift Tax is an introducer service. We are not a tax adviser, accountant or legal firm. The output of this checker is an indicator based on the answers you provide, calibrated against HMRC's published R&D tax relief criteria. Whether your company qualifies for relief, and the value of any claim, must be confirmed by an HMRC-registered specialist on the basis of a full review of your accounting period.

Indicative recovery values are based on the merged R&D scheme rate (20% above-the-line credit, approx. 15p per £1 net for profitable companies after corporation tax) and the ERIS rate (up to approx. 27p per £1 net for qualifying loss-making R&D-intensive SMEs at ≥30% intensity). They are not a guarantee of any specific recovery.

How R&D Tax Credits Are Calculated Under the Merged Scheme

Since accounting periods beginning on or after 1 April 2024, the UK's separate SME and RDEC schemes have merged into a single R&D relief with a 20% above-the-line credit on qualifying expenditure. "Above the line" means the credit is calculated on qualifying spend and treated as taxable income, then the company's normal corporation tax rate is applied to that credit. For a profitable company paying the 25% main rate of corporation tax, the arithmetic works out at approximately 15p of net benefit for every £1 of qualifying spend (20% credit, less 25% tax on that credit).

Worked example (illustrative, not a real company): a profitable engineering firm with £300,000 of qualifying R&D expenditure for the year receives a gross credit of £300,000 × 20% = £60,000. After corporation tax at the 25% main rate is applied to that credit, the net cash benefit is approximately £300,000 × 15% = £45,000.

Loss-making companies that are R&D-intensive, meaning qualifying R&D expenditure is at least 30% of total expenditure, can instead claim under Enhanced R&D Intensive Support (ERIS) at a higher net rate of up to approximately 27p per £1. Worked example (illustrative): a loss-making SME with £200,000 total expenditure and £80,000 of qualifying R&D spend has an R&D intensity of £80,000 / £200,000 = 40%, above the 30% ERIS threshold. Its indicative credit is £80,000 × 27% = £21,600, potentially receivable in part as a cash payment from HMRC, subject to the PAYE cap and standard statutory adjustments.

These figures are the same rates this calculator uses to produce your indicative range. The precise result for your company depends on the exact split of qualifying spend across HMRC's eight cost categories (see below) and whether your accounting period straddles the 1 April 2024 transition, which only a full review by an HMRC-registered specialist can confirm.

What Spend Qualifies for R&D Tax Credits?

HMRC recognises eight categories of qualifying R&D expenditure. This calculator's questions map to these categories; a full explanation of each, including common apportionment errors and what is excluded, is on our qualifying expenditure guide.

  • Staffing costs. Gross salary, employer National Insurance and employer pension contributions for staff working directly on qualifying R&D, apportioned by time spent.
  • Externally provided workers. Agency or contracted staff working under your direction on qualifying R&D, at a statutory restricted rate.
  • Subcontractors. Payments to unconnected UK subcontractors for qualifying R&D work, claimable at the 65% statutory rate under the merged scheme; overseas subcontractor cost is generally excluded, with a narrow statutory exception.
  • Software. Licences for software used directly in qualifying R&D activity.
  • Consumables. Materials and utilities consumed (not sold on) in qualifying R&D, such as prototype materials, test specimens and lab consumables.
  • Data and cloud costs. Cloud computing and licensed datasets used directly in R&D, qualifying since April 2023.
  • Clinical trial volunteer costs. Payments to volunteers in clinical trials, relevant to life sciences and medtech claimants.
  • Prototypes. Costs of building and testing a prototype where it is not intended for sale, distinct from commercial production costs.

Spend that does not resolve a genuine scientific or technological uncertainty, such as routine testing, project management, marketing or standard compliance work, is excluded regardless of which category it might otherwise fall into.

Common questions

No. It is an eligibility indicator only. We are an introducer service and explicitly do not provide tax advice. Confirmation of eligibility and the value of any claim is performed by an HMRC-registered specialist after a full review.

The values are based on the merged scheme rates and industry-typical apportionments. Actual recovery depends on the precise breakdown of qualifying expenditure across HMRC's eight cost categories, which only a specialist can calculate.

From accounting periods beginning on or after 1 April 2024, the UK's separate SME scheme and RDEC merged into a single R&D relief scheme with a 20% above-the-line credit. Loss-making R&D-intensive SMEs (≥30% intensity) can instead claim Enhanced R&D Intensive Support (ERIS) at a higher net rate. See the merged scheme explainer for the full picture.

Yes. The shareable permalink reproduces the same answers and result. The downloadable PDF report is designed to be forwarded to an accountant or to one of our specialist partners as a starting point for a full claim review.

If you submit your email to receive the PDF or be introduced to a specialist, your details are held per our privacy policy and used only for that purpose. Answers are not transmitted unless you click a submit button - the calculation runs entirely in your browser.

The calculator's questions map to HMRC's eight qualifying-expenditure categories: staffing, externally provided workers, subcontractors, software, consumables, data and cloud costs, clinical trial volunteers, and prototypes. See our full qualifying expenditure guide for category-by-category detail and common apportionment errors.

The merged scheme applies to accounting periods beginning on or after 1 April 2024. If your accounting period spans that date, HMRC's transitional rules determine how your specific period is treated; a specialist review confirms which scheme, or combination, governs your claim.

Prefer a human review?

Skip the calculator and request a free written eligibility assessment from our specialist network. No obligation.

Request a written assessment